Defining the right diluent for intravenous infusion of therapeutic antibodies

Therapeutic monoclonal antibodies (mAbs) are commonly administered to patients through intravenous (IV) infusion, which involves diluting the medication into an infusion solution (e.g., saline and 5% dextrose). Using the wrong diluent can cause product aggregation, which may compromise patient safet...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:MAbs
Prif Awduron: Luo, Shen, McSweeney, Keisha Melodi, Wang, Tao, Bacot, Silvia M., Feldman, Gerald M., Zhang, Baolin
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Taylor & Francis 2019
Pynciau:
Report
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6927757/
https://ncbi.nlm.nih.gov/pubmed/31774346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2019.1685814
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg